Myeloid Neoplasms Part II – Novel Therapies and Risk-adapted Personalized Treatment
We are excited to share recordings of Myeloid Neoplasms Part II – Novel Biomarkers for Diagnosis and Prognosis from the Women In Hematology US Focus Meeting 2025, held at the Hilton La Jolla Torrey Pines on November 7–8, 2025.